0 Комментарии
0 Поделились
567 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Offers
-
Jobs
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Biologic Medications for Psoriasis Market Expanding at 7.8% CAGR from 2026–2034 with Strong Industry AdoptionAccording to a new report from Intel Market Research, the global biologic medications for psoriasis market was valued at USD 14.5 billion in 2025 and is projected to reach USD 28.7 billion by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is fueled by increasing psoriasis prevalence, superior efficacy of biologics over conventional treatments, and...0 Комментарии 0 Поделились 941 Просмотры 0 предпросмотр
-
Broad-Spectrum Antiviral Therapeutics Market Advances with Growing Investment in Next-Generation Antiviral Drug Development and Pandemic PreparednessAccording to the latest report published by Data Bridge Market Research, the Broad-Spectrum Antiviral Therapeutics Market The global broad-spectrum antiviral therapeutics market size was valued at USD 5.84 billion in 2025 and is expected to reach USD 16.08 billion by 2033, at a CAGR of 13.50% during the forecast period This Broad-Spectrum Antiviral Therapeutics Market research report...0 Комментарии 0 Поделились 164 Просмотры 0 предпросмотр
-
Global Fosfomycin Sodium Market to Reach USD 680 Million by 2034 Amid Rising Antibiotic ResistanceAccording to a new report from Intel Market Research, the global Pets Internal Parasiticide market was valued at USD 2.77 billion in 2024 and is projected to reach USD 4.25 billion by 2034, growing at a steady CAGR of 6.5% during the forecast period (2025–2034). This expansion reflects increasing pet ownership worldwide coupled with growing awareness about zoonotic diseases and preventive...0 Комментарии 0 Поделились 814 Просмотры 0 предпросмотр
-
Global URTI Treatment Market to Reach USD 5.92 Billion by 2034 Driven by Rising Respiratory InfectionsAccording to a new report from Intel Market Research, the global Upper Respiratory Tract Infection Treatment market was valued at USD 3.45 billion in 2025 and is projected to reach USD 5.92 billion by 2034, growing at a CAGR of 6.1% during the forecast period (2026-2034). This growth is driven by increasing respiratory infection rates worldwide, higher healthcare expenditures, and advancements...0 Комментарии 0 Поделились 560 Просмотры 0 предпросмотр
-
Janus Kinases (JAKs) Inhibitor Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032 Driven by Rising Prevalence of Autoimmune Disorders and Advancements in Targeted TherapiesAccording to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030. This Janus Kinases (JAKs)...0 Комментарии 0 Поделились 515 Просмотры 0 предпросмотр
-
Mantle Cell Lymphoma Therapeutics Market to Reach USD 2.78 Billion by 2034, Driven by Advances in Targeted Therapies and CAR-T InnovationsAccording to a new report from Intel Market Research, the global Mantle Cell Lymphoma Therapeutics market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.78 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This expansion reflects growing clinical adoption of novel targeted therapies and increasing healthcare investments in...0 Комментарии 0 Поделились 847 Просмотры 0 предпросмотр
-
North America Anemia Drugs Market Set to Reach USD 5.9 Billion by 2032 Amid Rising CKD and Cancer CasesAccording to a new report from Intel Market Research, the North America Anemia Drugs Market was valued at USD 4,200 million in 2024 and is projected to grow from USD 4,410 million in 2025 to reach USD 5,900 million by 2032, growing at a CAGR of approximately 4.3% during the forecast period (2025–2032). This steady expansion is driven by the high and growing prevalence of chronic kidney...0 Комментарии 0 Поделились 630 Просмотры 0 предпросмотр
-
Oral Mucositis Drugs Market Size, Share, Growth Trends, Industry Analysis, and Forecast 2026–2032According to the latest report published by Data Bridge Market Research, the Oral Mucositis Drugs Market Data Bridge Market Research analyses that the global oral mucositis drugs market which was USD 530.00 million in 2023, would rocket up to USD 896.62 million by 2030, and is expected to undergo a CAGR of 7.80% during the forecast period Thorough and transparent research studies...0 Комментарии 0 Поделились 322 Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek